Skip to main content

Table 4 Tumor and liver dose correlations with anatomic/functional findings and administered activity

From: Safety and efficacy of Y-90 microsphere treatment in patients with primary and metastatic liver cancer: The tumor selectivity of the treatment as a function of tumor to liver flow ratio

  Tumor dose (Gy) Liver dose (Gy)
Tumor involvement (%) p = 0.003* p < 0.0001*
Tumor to liver ratio p < 0.0001* p = 0.47
Administered activity p > 0.99 p < 0.0001*
Disease type p = 0.65 p = 0.20